Stem Cell Therapy FAQs: Regenerative Treatment for Joint Pain

Stem cell therapy involves injecting cells that may help repair damaged cartilage and reduce inflammation in arthritic joints. The cells are usually harvested from your own bone marrow or fat tissue, concentrated, and then injected into the affected joint. The goal is to promote natural healing and slow joint degeneration.

The FDA has not approved stem cell therapy specifically for treating joint pain or osteoarthritis. While some stem cell products are FDA-approved for other medical uses, most clinics offering joint injections use minimally manipulated cells, which fall into a regulatory gray area. Be cautious of clinics claiming FDA approval for joint treatments.

Stem cell therapy for joints typically costs between $3,000 and $10,000 per treatment. The price depends on the source of cells, the provider, and your location. Most insurance plans, including Medicare and Medicaid, do not cover stem cell therapy for joint conditions because it is still considered experimental.

Early research shows some promise for stem cell therapy in treating knee osteoarthritis, but high-quality evidence is limited. Most studies are small and short-term. There are no large-scale randomized controlled trials proving long-term benefit. More research is needed before it can be considered a proven treatment.

Risks include infection at the injection site, pain and swelling, nerve damage, and the possibility that the treatment will not work. Some unregulated clinics use procedures that carry higher risks. Serious complications are rare but have been reported, including infections from improperly processed cells.

Both are regenerative treatments, but they work differently. PRP uses concentrated platelets from your blood to promote healing. Stem cell therapy uses cells that may develop into cartilage tissue. PRP is less expensive ($500-$2,000 vs. $3,000-$10,000) and has somewhat more published research. Neither is covered by most insurance plans.

HA injections (viscosupplementation) are FDA-approved, well-studied, and covered by Medicare and most insurance plans. They lubricate the joint and provide 6-12 months of relief. Stem cell therapy is not FDA-approved for joints and costs much more. For most patients, HA injections offer a proven, accessible option.

Potential candidates have mild-to-moderate osteoarthritis, have not responded to standard treatments, and are willing to pay out of pocket. It is generally not recommended for severe arthritis with significant bone-on-bone damage. A thorough evaluation by an orthopedic specialist is essential before considering this treatment.

No. Medicare, Medicaid, and nearly all private insurance plans do not cover stem cell therapy for joint conditions. It is classified as experimental or investigational. You should be prepared to pay the full cost out of pocket if you choose this treatment.

Ask about the source of the stem cells, the provider's specific training and experience, how many procedures they have performed, what outcomes their patients typically experience, and whether they have published any research. Also ask about the total cost, what is included, and what happens if the treatment does not work.